Stericycle (NASDAQ:SRCL) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued to investors on Wednesday.
Other equities research analysts have also issued research reports about the stock. Northcoast Research reaffirmed a “neutral” rating on shares of Stericycle in a report on Friday, October 12th. Robert W. Baird reaffirmed a “hold” rating on shares of Stericycle in a report on Tuesday. BMO Capital Markets dropped their target price on shares of Stericycle from $58.00 to $51.00 and set a “market perform” rating for the company in a report on Tuesday. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Tuesday, August 28th. Finally, Jefferies Financial Group set a $75.00 target price on shares of Stericycle and gave the stock a “buy” rating in a report on Thursday, August 2nd. Five analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $65.38.
Shares of NASDAQ SRCL opened at $46.80 on Wednesday. The firm has a market capitalization of $4.06 billion, a P/E ratio of 10.78, a P/E/G ratio of 1.24 and a beta of 0.52. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.93. Stericycle has a one year low of $45.55 and a one year high of $76.73.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, November 1st. The business services provider reported $1.03 EPS for the quarter, topping the consensus estimate of $1.01 by $0.02. The company had revenue of $854.90 million during the quarter, compared to analyst estimates of $856.36 million. Stericycle had a net margin of 4.63% and a return on equity of 13.74%. The firm’s revenue was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.10 EPS. Equities research analysts expect that Stericycle will post 4.37 earnings per share for the current year.
Several institutional investors have recently added to or reduced their stakes in SRCL. DnB Asset Management AS acquired a new position in shares of Stericycle during the 2nd quarter valued at about $692,000. IFM Investors Pty Ltd boosted its position in shares of Stericycle by 32.6% during the 2nd quarter. IFM Investors Pty Ltd now owns 5,056 shares of the business services provider’s stock valued at $330,000 after acquiring an additional 1,243 shares during the last quarter. Fulton Bank N.A. boosted its position in shares of Stericycle by 15.6% during the 2nd quarter. Fulton Bank N.A. now owns 10,161 shares of the business services provider’s stock valued at $663,000 after acquiring an additional 1,370 shares during the last quarter. Radnor Capital Management LLC acquired a new position in shares of Stericycle during the 2nd quarter valued at about $438,000. Finally, State of Alaska Department of Revenue boosted its position in shares of Stericycle by 14.6% during the 2nd quarter. State of Alaska Department of Revenue now owns 20,540 shares of the business services provider’s stock valued at $1,340,000 after acquiring an additional 2,620 shares during the last quarter. 95.11% of the stock is owned by institutional investors and hedge funds.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Featured Story: Outstanding Shares, Buying and Selling Stocks
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.